Search

Calmare NJ USA

Tag

chemo induced peripheral neuropathy

A Better Therapy to Treat Nerve Damage after Chemotherapy (CIPN)

September 13, 2018

Calmare for cancer painChemotherapy-induced peripheral neuropathy or CIPN is caused by the heavy metals in the these medications which strive to eradicate cancer cells, but may also cause significant nerve damage in the process.

The after-effects of this neuropathy can significantly diminish the patient’s quality of life, even after the cancer is gone.

A combination of studies has found that more than 50 percent of chemo patients suffer from CIPN, a tremendously painful condition that is famously difficult to treat with traditional medication, most commonly Cymbalta, Lyrica, or Gabapentin, and standard pain management strategies.

It can also reduce the quality of life due to chronic tingling and numbness in the hands and feet.  Mobility and other essential activities of daily living can become impossible.

That’s why the news from several studies, including the University of Wisconsin, the Massey Cancer Institute, and the Mayo Clinic are so important.

National Institute of Health Reports on Scrambler Therapy study with CIPN patients.

These centers’ studies have confirmed that Calmare’s scrambler therapy is producing significantly positive results in minimizing or even eliminating pain from chemotherapy treatment.

“The FDA cleared the Calmare MC-5A device specifically to treat patients

with neuropathy as a result of chemotherapy,” says Dr. Michael Cooney.

“We have treated patients with CIPN since 2011 and have seen

dramatically positive outcomes firsthand.”

 

Deena and Dr. Cooney during her Calmare Therapy treatment sessions for CIPN (2017).

Deena uses Calmare scrambler therapy to combat pain from CRPS and nerve pain after chemo.

These findings, reported by top U.S. cancer centers, serve as a light at the end of a long, dark tunnel of pain for our friends, family and colleagues living with the painful after-effects of chemotherapy treatment.

We welcome you to contact us to learn more about using scrambler therapy as a non-invasive, painless treatment for nerve pain after cancer treatment.

Also important, the treatments have no side effects.

Nelia describes her Calmare Therapy to lessen CIPN

Fill out the info card below and we’ll reach out to you.

Or, feel free to call the clinic at (201) 933-4440 and speak with our friendly and knowledgeable Calmare team.

Medscape reports on another positive clinical trial using Calmare for cancer pain

medscapeAnother Calmare Therapy clinical trial, conducted with people battling neuropathic pain as a result of chemotherapy treatment, has again shown  positive patient outcomes (significant lessening of pain) according to a new report published this week by Medscape, an affiliate of WebMD. (You have to register to read the article, but the process is free, quick and easy).

clinical trialCalmare Trial Key Points / Excerpts:

  • Scrambler therapy was not originally developed for the treatment of cancer-related neuropathic pain. Rather, it was developed for chronic pain and, indeed, has been used in many patients with noncancer-related pain, including low back pain.
  • Regardless of the type of neuropathic pain being treated, scores on the 11-point Numerical Rating Scale (NRS) decreased significantly from baseline to 1-month follow-up (P < .001).
  • The need for ‘rescue opioids’ dropped from a baseline dose of 5 mg to 0 mg at the end of the study.
  • No adverse side effects (“events”) that could have been associated with the therapy were reported.
  • A research team from the Massey Cancer Center at Virginia Commonwealth University in Richmond reported similar findings using the same cutaneous electro-stimulation device (scrambler therapy) for CIPN (J Pain Symptom Manage. 2010;40:883-891).
  • Some patients relapsed, but re-treatment and maintenance therapy (booster treatments) provided relief and, again, no adverse effects from treatment were observed.
  • Charles Loprinzi, MD, PhD, from the Mayo Clinic in Rochester, Minnesota, and colleagues conducted a trial with 37 CIPN patients and achieved similar study outcomes (Support Care Cancer. 2015 23:943-951).
  • Dr. Loprinzi stated that people have been slow to explore scrambler therapy use because “it sounds too good to be true…” He also reported to Medscape that efforts to conduct larger trials are ongoing, but it takes time and money to perform these trials.

The European Journal of Oncology Nursing also published an abstract of the study reported by Medscape.


NEWS12 to Feature Dr. Michael Cooney and Calmare Therapy

Dr. Michael Cooney has just completed shooting a “To Your Health” with Dr. Derrick DeSilva segment for News12 where he discusses Calmare Pain Therapy Treatment. His patient, Laura Miller, an RSD and fibromyalgia sufferer for more than three years, also appeared on the program to discuss her condition, other painful and expensive chronic pain treatments that ultimately proved to be unsuccessful, and the final resolution of her pain after undergoing Calmare Therapy.

“News12 is one of the few television stations to prioritize healthcare news,” says Dr. Cooney. “They recognized the importance of informing viewers living with chronic pain that there is a new solution available to help these patients take control of their lives again.”

The Calmare Therapy segment featuring Dr. Cooney and Laura Miller will air January, 2012.

Blog at WordPress.com.

Up ↑

%d bloggers like this: